X. Long Zheng/LinkedIn
Oct 17, 2026, 15:41
X. Long Zheng։ ADAMTS13 and VWF in COVID-19-Associated Coagulopathy
X. Long Zheng, Professor and Chair of Pathology and Laboratory Medicine at The University of Kansas, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers in Cardiovascular Medicine, adding:
”A new review article from my former trainee Quan Zhang in China describes in detail the role of ADAMTS13 and VWF axis in pathogenesis of COVID-19 associated coagulopathy.
We welcome the comments and critics.”
Title: The role of VWF/ADAMTS13 axis in COVID-19-associated coagulopathy
Authors: Quan Zhang, Ye Tan, Meijuan Peng, Shangjie Wu, X. Long Zheng
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 14:59Diwakar Mittal: From Dialogue to Action: Advancing Sickle Cell Disease Care in India
-
Oct 17, 2026, 12:21Jalen Hurts Sidelined by a Superficial Blood Clot: What to Know
-
Oct 17, 2026, 09:33Robert Lookstein: Mechanical Thrombectomy Shows Functional Benefits in Intermediate-High-Risk PE
-
Oct 17, 2026, 09:18Sarra Hmidi: Tunisia Highlights Thrombosis Prevention on World Thrombosis Day
-
Oct 17, 2026, 09:05Addressing the Hidden Burden of Bleeding Disorders in Women – Hemophilia Society Mumbai Chapter
-
Oct 17, 2026, 08:49Maria Magnusson: Karolinska Experts Explore Gene Therapy in Sickle Cell Disease and Hemophilia
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways